Sanofi CEO on AI's Impact, Lung Disease Drug Clearance
July 3, 2024
4,642
53
3
1.21%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg Technology Episodes Around July 3, 2024
See what was published immediately before and after this episode.
8:54Now PlayingSanofi CEO on AI's Impact, Lung Disease Drug Clearance
YouTube Description
as posted by the channelSanofi CEO Paul Hudson joins Caroline Hyde to discuss the company's integration of AI tools in everyday operations, the impact of AI on the biopharma sector, and the company's Dupixent drug getting cleared for a chronic lung disorder in the European Union, creating another avenue of growth for the blockbuster drug. He speaks on "Bloomberg Technology."
--------
Like this video? Subscribe to Bloomberg Technology on YouTube:
Watch the latest full episodes of "Bloomberg Technology" with Caroline Hyde and Ed Ludlow here:
Get the latest in tech from Silicon Valley and around the world here:
Connect with us on...
Follow Ed Ludlow on X here
Follow Caroline Hyde on X here
Listen to the daily Bloomberg Technology podcast here:
More from Bloomberg Business
Connect with us on...
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.